1 story in the last 7 days
The latest nuvalent news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks nuvalent across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
GSK acquired Nuvalent for $10.6 billion to expand its cancer portfolio after previously winding down the area. The move marks GSK's largest acquisition in eight years. The deal aims to reverse prior reductions in cancer-focused research and development.
Summaries by ByteBrief